drugset / Trial / NCT06209229

Role of Neutrophils and Electro-bioluminescence in the Rehabilitation

NCT06209229

Phase 1 Completed 34 enrolled MIPO Clinic
NaSingle-groupOpen-labelSupportive care

Summary

The clinical study is to find out the effect of a course of immunomodulatory drugs and detoxification scheme on finger bioelectroluminescence and neutrophil function and their correlation with changes in quality of life and life expectancy in patients with malignant diseases against the background of restorative treatment and rehabilitation. Questions: 1. does the quality of life of patients with lung cancer change with the use of a course of immunomodulatory drugs and detoxification scheme? 2. does phagocytosis function, liposomal activity, mitochondrial function of neutrophils change against the background of the course? 3. does bioluminescence of fingers of hands change against the background of the course of immunotherapy? Participants will take Calcitreol capsules, Magnesium B-6 capsules, products containing quercetin flavonoids, Naderin (sodium deoxeribonucleate) daily for 21 days. before the course, after the course and after one year they will answer the QLQ-LC13, WHOQOL BREF, L.H. Garkavi adaptation self-assessment questionnaire and give blood for laboratory analysis of neutrophil function assessment.

Timeline

Start
2022-05-01
Primary completion
2023-05-01
Completion
2023-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Calcitriol Small molecule 5000 iu
Subject Cholecalciferol Other / unclassified Oral
Subject Magnesium Sulfate Other / unclassified 470 mg Oral
Subject Pyridoxine Unknown 5 mg Oral
Subject Quercetin Small molecule 1000 mg Oral